Physician profile
Sheel Sharma
NPI 1144266966
$9,284.63
in general payments reported to CMS, 2019-2025
8 companies · $73.72 in 2025
The $73.72 reported for 2025 was less than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,572 · 2022: $369 · 2023: $141 · 2024: $129 · 2025: $73.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $8,572.00 | 2019 | |
| Integra Lifesciences Corporation | $247.78 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sientra, INC. | $136.04 | 2022 | |
| Sonex Health, INC. | $125.78 | 2022 | |
| Endo Pharmaceuticals INC. | $101.99 | 2024 | Xiaflex |
| Innovation Technologies INC | $44.41 | 2025 | Irrisept |
| Solventum Corporation | $29.31 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Suvon Surgical LLC | $27.32 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheel Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.